Annabel Maruani
4
Documents
Identifiants chercheurs
- annabel-maruani
- ResearcherId : L-9017-2015
- IdRef : 088646270
- 0000-0003-3734-810X
- ResearcherId : http://www.researcherid.com/rid/L-9017-2015
Présentation
Publications
- 4
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 4
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
Vascular endothelial growth factor, tissue factor, coagulation and fibrinolysis markers in slow-flow vascular malformations: a prospective study of treatment with sirolimusBritish Journal of Dermatology, 2023, 188 (1), pp.152-154. ⟨10.1093/bjd/ljac028⟩
Article dans une revue
hal-04233650v1
|
Sirolimus (Rapamycin) for Slow-Flow Malformations in ChildrenJAMA Dermatology, In press, ⟨10.1001/jamadermatol.2021.3459⟩
Article dans une revue
hal-03408026v1
|
|
Vascular Mass of the Scalp in a Newborn: A QuizActa Dermato-Venereologica, 2019, 99 (6), pp.627-628. ⟨10.2340/00015555-3131⟩
Article dans une revue
hal-03158785v1
|
|
|
Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase designTrials, 2018, 19 (1), pp.340. ⟨10.1186/s13063-018-2725-1⟩
Article dans une revue
hal-01913363v1
|